Titlebook: Antibody-Drug Conjugates; Laurent Ducry Book 2013 Springer Science+Business Media, LLC 2013 ADCs.Anti-cancer biotherapeutics.Antigen-targe

只看該作者 · 發(fā)表于 2025-3-23 16:25:03

Methods for Conjugating Antibodies to Nanocarriers,

只看該作者 · 發(fā)表于 2025-3-23 20:20:36

Drug-to-Antibody Ratio (DAR) by UV/Vis Spectroscopy,

只看該作者 · 發(fā)表于 2025-3-24 00:09:39

只看該作者 · 發(fā)表于 2025-3-24 05:41:42

Drug-to-Antibody Ratio (DAR) and Drug Load Distribution by LC-ESI-MS,

只看該作者 · 發(fā)表于 2025-3-24 10:28:29

Determination of Charge Heterogeneity and Level of Unconjugated Antibody by Imaged cIEF,

只看該作者 · 發(fā)表于 2025-3-24 11:35:07

只看該作者 · 發(fā)表于 2025-3-24 16:58:40

只看該作者 · 發(fā)表于 2025-3-24 21:27:39

1064-3745 cible.Features expert tips and key implementation advice to .Antibody-drug conjugates (ADCs) represent a promising therapeutic approach for cancer patients by combining the antigen-targeting specificity of monoclonal antibodies (mAbs) with the cytotoxic potency of chemotherapeutic drugs.? In .Antibo

只看該作者 · 發(fā)表于 2025-3-24 23:37:19

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-27 20:07
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved